Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Whitehawk Therapeutics (WHWK) Other Non-Current Liabilities: 2020-2024

  • Whitehawk Therapeutics' Other Non-Current Liabilities was N/A to $202,000 in Q4 2024 from the same period last year, while for Dec 2024 it was $202,000, marking a year-over-year change of. This contributed to the annual value of $202,000 for FY2024, which is N/A change from last year.
  • As of Q4 2024, Whitehawk Therapeutics' Other Non-Current Liabilities stood at $202,000, which was down 48.60% from $393,000 recorded in Q3 2024.
  • In the past 5 years, Whitehawk Therapeutics' Other Non-Current Liabilities registered a high of $393,000 during Q3 2024, and its lowest value of $97,000 during Q4 2020.
  • For the 2-year period, Whitehawk Therapeutics' Other Non-Current Liabilities averaged around $234,667, with its median value being $202,000 (2024).